181 related articles for article (PubMed ID: 33973537)
21. The Effect of Diagnostic Ureterorenoscopy on Intravesical Recurrence in Patients Undergoing Nephroureterectomy for Primary Upper Tract Urinary Carcinoma.
İzol V; Deger M; Ozden E; Bolat D; Argun B; Baltaci S; Celik O; Akgul HM; Tinay İ; Bayazit Y;
Urol Int; 2021; 105(3-4):291-297. PubMed ID: 33264798
[TBL] [Abstract][Full Text] [Related]
22. Impact of renal function on eligibility for chemotherapy and survival in patients who have undergone radical nephro-ureterectomy.
Xylinas E; Rink M; Margulis V; Clozel T; Lee RK; Comploj E; Novara G; Raman JD; Lotan Y; Weizer A; Roupret M; Pycha A; Scherr DS; Seitz C; Ficarra V; Trinh QD; Karakiewicz PI; Montorsi F; Zerbib M; Shariat SF;
BJU Int; 2013 Aug; 112(4):453-61. PubMed ID: 23464979
[TBL] [Abstract][Full Text] [Related]
23. Prognostic Analysis of Diagnostic Ureteroscopic Biopsy for Intravesical Recurrence of Upper Urinary Tract Urothelial Carcinoma.
Chen H; Wang M; Weng T; Wei Y; Yang L; Ren K; Tang Z; Gou X
Urol Int; 2022; 106(2):186-194. PubMed ID: 34492655
[TBL] [Abstract][Full Text] [Related]
24. Consultation on UTUC, Stockholm 2018: aspects of treatment.
Jung H; Giusti G; Fajkovic H; Herrmann T; Jones R; Straub M; Baard J; Osther PJS; Brehmer M
World J Urol; 2019 Nov; 37(11):2279-2287. PubMed ID: 31123852
[TBL] [Abstract][Full Text] [Related]
25. Preoperative Pyuria Predicts for Intravesical Recurrence in Patients With Urothelial Carcinoma of the Upper Urinary Tract After Radical Nephroureterectomy Without a History of Bladder Cancer.
Sato G; Yoshida T; Yanishi M; Saito R; Murota T; Kawa G; Kinoshita H; Matsuda T
Clin Genitourin Cancer; 2020 Apr; 18(2):e167-e173. PubMed ID: 31635939
[TBL] [Abstract][Full Text] [Related]
26. Potential Benefit of Lymph Node Dissection During Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the European Association of Urology Guidelines Panel on Non-muscle-invasive Bladder Cancer.
Dominguez-Escrig JL; Peyronnet B; Seisen T; Bruins HM; Yuan CY; Babjuk M; Böhle A; Burger M; Compérat EM; Gontero P; Lam T; MacLennan S; Mostafid H; Palou J; van Rhijn BWG; Sylvester RJ; Zigeuner R; Shariat SF; Rouprêt M
Eur Urol Focus; 2019 Mar; 5(2):224-241. PubMed ID: 29158169
[TBL] [Abstract][Full Text] [Related]
27. Contemporary role of lymph node dissection at the time of radical nephroureterectomy for upper tract urothelial carcinoma.
Seisen T; Shariat SF; Cussenot O; Peyronnet B; Renard-Penna R; Colin P; Rouprêt M
World J Urol; 2017 Apr; 35(4):535-548. PubMed ID: 26809456
[TBL] [Abstract][Full Text] [Related]
28. Bladder mapping of tumour recurrence after radical nephroureterectomy for upper tract urothelial carcinoma and its influence on oncological outcomes.
Belhadj Y; Grande P; Seisen T; Gobert A; Gomez FD; Cussenot O; Roupret M
BJU Int; 2019 Apr; 123(4):618-623. PubMed ID: 30548115
[TBL] [Abstract][Full Text] [Related]
29. European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 Update.
Rouprêt M; Babjuk M; Compérat E; Zigeuner R; Sylvester RJ; Burger M; Cowan NC; Böhle A; Van Rhijn BW; Kaasinen E; Palou J; Shariat SF
Eur Urol; 2015 Nov; 68(5):868-79. PubMed ID: 26188393
[TBL] [Abstract][Full Text] [Related]
30. The clinicopathological characteristics of muscle-invasive bladder recurrence in upper tract urothelial carcinoma.
Shigeta K; Matsumoto K; Ogihara K; Murakami T; Anno T; Umeda K; Izawa M; Baba Y; Sanjo T; Shojo K; Tanaka N; Takeda T; Kosaka T; Mizuno R; Mikami S; Kikuchi E; Oya M
Cancer Sci; 2021 Mar; 112(3):1084-1094. PubMed ID: 33368857
[TBL] [Abstract][Full Text] [Related]
31. Initial experience of complete laparoscopic radical nephroureterectomy combined with transvesical laparoscopic excision of distal ureter in patients with upper urinary tract cancer.
Miyake M; Nishimura N; Aoki K; Ohmori C; Shimizu T; Owari T; Hori S; Morizawa Y; Gotoh D; Nakai Y; Anai S; Torimoto K; Tanaka N; Fujimoto K
World J Surg Oncol; 2020 May; 18(1):104. PubMed ID: 32450850
[TBL] [Abstract][Full Text] [Related]
32. Nephroureterectomy vs. segmental ureterectomy of clinically localized, high-grade, urothelial carcinoma of the ureter: Practice patterns and outcomes.
Piraino JA; Snow ZA; Edwards DC; Hager S; McGreen BH; Diorio GJ
Urol Oncol; 2020 Nov; 38(11):851.e1-851.e10. PubMed ID: 32859461
[TBL] [Abstract][Full Text] [Related]
33. Perioperative and oncological outcomes of distal ureter management during nephroureterectomy for upper urinary tract urothelial carcinoma: a systematic review and meta-analysis.
Gallioli A; Baboudjian M; Diana P; Moschini M; Xylinas E; Del Giudice F; Laukhtina E; Soria F; Mari A; Subiela JD; Rouy M; Territo A; Basile G; Palou J; Pradere B; Breda A;
Minerva Urol Nephrol; 2023 Dec; 75(6):672-682. PubMed ID: 38126282
[TBL] [Abstract][Full Text] [Related]
34. Prognostic value of plasma fibrinogen levels in patients with localized upper tract urothelial carcinoma.
Tanaka N; Kikuchi E; Matsumoto K; Hayakawa N; Ide H; Miyajima A; Nakamura S; Oya M
BJU Int; 2013 May; 111(6):857-64. PubMed ID: 22757942
[TBL] [Abstract][Full Text] [Related]
35. Oncologic Surveillance After Radical Nephroureterectomy for High-risk Upper Tract Urothelial Carcinoma.
Martini A; Lonati C; Nocera L; Fallara G; Raggi D; Herout R; Zamboni S; Ploussard G; Predere B; Mattei A; Simeone C; Krajewski W; Simone G; Soria F; Gontero P; Roupret M; Montorsi F; Briganti A; Shariat SF; Necchi A; Moschini M
Eur Urol Oncol; 2022 Aug; 5(4):451-459. PubMed ID: 35504834
[TBL] [Abstract][Full Text] [Related]
36. Management of the Distal Ureter During Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Comprehensive Review of Literature.
Morriss S; Zargar H; Dias BH
Urol J; 2021 Nov; 18(6):585-599. PubMed ID: 34746998
[TBL] [Abstract][Full Text] [Related]
37. Effects of different combinations of radical nephroureterectomy and bladder cuff excision procedures for upper tract urothelial carcinoma on bladder recurrence.
Huang EY; Tai MC; Chung HJ; Chang YH; Huang WJ
Int Braz J Urol; 2023; 49(4):469-478. PubMed ID: 37267612
[TBL] [Abstract][Full Text] [Related]
38. Upper urinary tract recurrence following bladder cancer therapy: a review of surveillance and management.
Naser-Tavakolian A; Ghodoussipour S; Djaladat H
Curr Opin Urol; 2019 May; 29(3):189-197. PubMed ID: 30762673
[TBL] [Abstract][Full Text] [Related]
39. Patient characteristics and outcomes in metastatic upper tract urothelial carcinoma after radical nephroureterectomy: the experience of Japanese multi-institutions.
Tanaka N; Kikuchi E; Kanao K; Matsumoto K; Kobayashi H; Miyazaki Y; Ide H; Obata J; Hoshino K; Shirotake S; Hayakawa N; Kosaka T; Miyajima A; Momma T; Nakagawa K; Hasegawa S; Nakajima Y; Oya M
BJU Int; 2013 Jul; 112(2):E28-34. PubMed ID: 23795795
[TBL] [Abstract][Full Text] [Related]
40. Impact of smoking on oncologic outcomes of upper tract urothelial carcinoma after radical nephroureterectomy.
Rink M; Xylinas E; Margulis V; Cha EK; Ehdaie B; Raman JD; Chun FK; Matsumoto K; Lotan Y; Furberg H; Babjuk M; Pycha A; Wood CG; Karakiewicz PI; Fisch M; Scherr DS; Shariat SF;
Eur Urol; 2013 Jun; 63(6):1082-90. PubMed ID: 22743166
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
